Abstract
Cancer patients, irradiated in the neck region, often develop oral candidosis and a substantial decrease in salivary flow after irradiation. As the use of a bioadhesive buccal tablet containing miconazole nitrate has been shown to be effective in the treatment of oral candidosis, the influence of the application site on the buccal levels of miconazole nitrate was studied. The t MAX the adhesion time and T >MIC were significantly higher ( P < 0.05) when the gingiva was chosen as the application site in comparison with the cheek. The C MAX, t MAX and AUC were not significantly different. The gingiva is the application site of choice in irradiated patients even with a decreased salivary flow.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
